StocksEli Lilly & CoLLY

LLY

Eli Lilly & Co

316.67 0.40 (0.13%)
Delayed Prices By NASDAQ, in USD Market Closed
Trade
S
316.67
B
317.36

Overview

Prev Close316.67
Day's Range 313.86 - 317.87
52 Week Range 219.94 - 334.60
Average Volume (3m)2.86M
1-Year Return17.27%
Beta0.6639
Market Cap300.94B
P/E Ratio50.51
Revenue29.07B
EPS6.2709
Dividend (Yield)3.79 (1.20%)
1 Day 1 Week 1 Month 3 Months 6 Months 1 Year 3 Years Max
Created with Highcharts 4.2.7 /Highstock 4.2.710/03/202219/05/202201/08/2022240.00260.00280.00300.00320.00340.00
Chart times in UTC
Industry Pharmaceuticals Major
CEO David A. Ricks, MBA
Employees 35,000

FINANCIAL SUMMARY

For the fiscal year ended 31/12/2021: Eli Lilly & Co's revenues increased by 15.40% and amounted to 28.32B. Net income decreased by 9.88% to 5.58B. Net assets decreased by NaN to N/A and EPS decreased from 6.79 to 6.12.
LLY's Investor Relations
Income StatementBalance SheetCash Flow Statement
Quarterly
Gross Margin
75.98%
Net Profit Margin
15.90%
Operating Margin
29.84%
Return On Investment
18.77%
09/21
12/21
03/22
06/22
Total Revenue
6.77B
8B
7.81B
6.49B
Gross Profit
5.48B
6.08B
5.94B
5.18B
Operating Income
2.06B
2.4B
2.57B
1.65B
Net Income
1.11B
1.73B
1.9B
952.5M